Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Omori

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profilesYuusuke Tamura, Naoki Omori, Naoki Kouyama, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2012
Identification of a novel and orally available benzimidazole derivative as an NPY Y5 receptor antagonist with in vivo efficacyYuusuke Tamura, Naoki Omori, Naoki Kouyama, et al.
Brain Research|December 8, 2022
Analysis of the time-dependent changes of phospholipids in the brain regions of a mouse model of Alzheimer's diseaseMd Ahsanul Haque, Naoki Omori, Abdullah Md Sheikh, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2012
Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonistNaoki Omori, Naoki Kouyama, Akira Yukimasa, et al.
Autoimmunity|November 27, 2018
Polymorphisms in Th17-related genes and the pathogenesis of autoimmune thyroid diseaseTakayuki Kunisato, Mikio Watanabe, Naoya Inoue, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2011
Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinasesNaoyuki Suzuki, Takeshi Shiota, Fumihiko Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2012
Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profileYuusuke Tamura, Kyouhei Hayashi, Naoki Omori, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profilesYuusuke Tamura, Naoki Omori, Naoki Kouyama, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2012
Identification of a novel and orally available benzimidazole derivative as an NPY Y5 receptor antagonist with in vivo efficacyYuusuke Tamura, Naoki Omori, Naoki Kouyama, et al.
Brain Research|December 8, 2022
Analysis of the time-dependent changes of phospholipids in the brain regions of a mouse model of Alzheimer's diseaseMd Ahsanul Haque, Naoki Omori, Abdullah Md Sheikh, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2012
Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonistNaoki Omori, Naoki Kouyama, Akira Yukimasa, et al.
Autoimmunity|November 27, 2018
Polymorphisms in Th17-related genes and the pathogenesis of autoimmune thyroid diseaseTakayuki Kunisato, Mikio Watanabe, Naoya Inoue, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2011
Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinasesNaoyuki Suzuki, Takeshi Shiota, Fumihiko Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2012
Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profileYuusuke Tamura, Kyouhei Hayashi, Naoki Omori, et al.
Pageof 2